Menu
Washingtoner
  • Home
  • Business
  • Technology
  • Health
  • Construction
  • Arts
  • Information Technology
  • Transportation
  • Home
Washingtoner

Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation
Washingtoner/10292390

Trending...
  • Wealthywet's Miami Swim Week 2025 Debut Signals a New Era of Luxury in Swimwear
  • Emerge Apps Launches Mod Performance Suite: A New Era of Work Comp Selling for Insurance Agents
  • Advanced Solar Space Technology; Record Efficiency of 15.7%; Agreement to Provide NOVI Space with Rollable PV Array Blankets for Space Launch in 2026
Figure 3 Graphic Depictions Of Cognitive Changes Combined Subject Eeg Topo Map Pre And Post Certified Nutraceuticals, Inc.
The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports.

TEMECULA, Calif. - Washingtoner -- Jellyfish Publication-Certified Nutraceuticals, Inc.

Gerald M. Haase, M.D.
Clinical Professor of Surgery, University of Colorado School of Medicine, Aurora, CO.

Neil E. Wolkodoff, PhD
Medical Program Director, Colorado Center for Health and Sports Science, Denver, CO.
May 16, 2025

Certified Nutraceuticals, Inc., a research and product development enterprise in Pauma Valley, California, U.S.A., announces the publication of an exciting new human clinical trial of its proprietary KollaJell™ collagen peptide formulation.

The research study of this unique jellyfish collagen-based supplement was published in the peer-reviewed medical source, the Journal of Clinical Research and Reports. The strength of this prospective, randomized trial is the distinctive utilization of a panel of brain function metrics from two robust, validated instruments, including a computerized neurocognitive test battery and an electroencephalographic (EEG) profile of voltage activation and wave phase pattern. Instead of evaluating only one or two parameters, this investigation assessed seven domains of cognitive function in 23 subjects who consumed KollaJell™ for a period of eight weeks.

More on Washingtoner
  • The Somm. Hotel at Harvest to Host Auction of Washington Wines Gala Event
  • DivX Enhances AVI Playback Resources; Simplifies Guide to Playing AVI Files with DivX Software
  • Patrick Aloni Joins Historic Gold and Copper Discovery in Argentina with Multimillion-Dollar Stake
  • Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures
  • AI-Powered Retail Media Platform PulseAd Enters $280B US Market with Seattle Operations

The outcomes were clinically relevant, and all were statistically analyzed and achieved statistical significance. Standard scores matched for age and gender improved in all metrics regardless of the functional status of where the subject started. The parameters included compositive memory, neurocognitive index, visual memory, executive function and verbal memory. Under EEG monitoring conditions, the mean total reaction time and the trail-making composite test times also decreased dramatically. Topographic brain images showed voltage activation in the brain regions associated with sensory input and processing function. There were no adverse effects of consuming the supplement in any subject at any time during the study.

The importance of this pilot trial is the demonstration of a particularly extensive spectrum of beneficial results from the proprietary formulation compared to competing products that, even if helpful, provide only limited effects. In addition, the use of a marine-based natural collagen was superior to the usual animal-based products and the patented extraction process provided a greater platform of collagen types and a uniquely effective amino acid composition. This human clinical trial reinforces the concept that Certified Nutraceuticals KollaJell™ is a safe and beneficial collagen supplement that supports cognitive domains and memory and is applicable to a wide audience of potential consumers, regardless of their initial brain function status.

More on Washingtoner
  • Spokane: 2025 Pools
  • Goldstar Rehabilitation Celebrates 15 Years of Early Intervention Across Southeastern PA
  • United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
  • D8Averse Launches D8Acapture: Disruptive Mobile-First App Transforms Utility Pole Data Collection
  • Experience Trembling Firsthand with the New AgeMan® Tremor Simulator

The actual medical study is available as a free open-access publication at https://www.auctoresonline.org/article/effects-of-a-jellyfish-collagen-based-amino-acid-supplement-on-cognitive-function-and-memory-a-pilot-investigation

For further information about the product or study, please contact:

Sara Alkayali at (951) 600-3899 or email: salkayali@certifiednutra.com

Contact
Sara Alkayali
***@certifiednutra.com
951-600-3899


Source: Certified Nutraceuticals, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Vice President JD Vance & Industry Leaders at Bitcoin Conference After Partnership Signing to Optimize Cybersecurity Solutions: Bullet Blockchain, Inc
  • Actress/Comedian Schelle Purcell Sizzles This Summer with Star-Making Turn in Tyler Perry's #1 Netflix Film, Straw, and Upcoming Comedy Special
  • Braxus Entertainment Group Acquires All Star Events
  • Global Expansion Fueled via Agreement to Take 90% Ownership of Nook Holdings UAE-Based Sports Incubator by Online Lottery & Sports Game Provider
  • Remember Internet Pioneers NetCom Solutions & Network Solutions? Founder Emmit J. McHenry is Now Leading the Emerging Cybersecurity Firm Cycurion
  • Celebrating Father's Day Weekend with Free Admission for the entire Family, AKC Dog Show, Best in Show and Puppy Event, Product Vendors
  • LIB Continuous Innovation: Custom Rain Test Chambers & IP Labs
  • csky.ai & DuoKey Launch Secure AI Transcription Solution for Microsoft 365
  • PlayClay.io Launches Streamlined Quoting Platform for Manufacturers' Reps and Distributors
  • From Hotel Discomfort to Bamboo Bliss: BedVoyage Redefines Travel Sleep
  • Nordstrom Rack to Open New Location in Pompano Beach, FL
  • Let's Talk Series: At the Crossroads: Immigration Today
  • Cyta Cyprus Selects Axiros' AXESS Platform for Cloud-Native, Data-Driven Device Management
  • Spokane: City Provides Annual Report on Drinking Water Quality
  • DealMagik Successfully Concludes National Floral Design Contest with Over 150 Submissions
  • Behavioral Health Advocates to Hold Joint Capitol Hill Press Conference on June 11
  • VNBTC Becomes The Top Crypto Investment Platform As Its Bitcoin Cloud Mining Solution Goes Viral
  • Advanced Solar Space Technology; Record Efficiency of 15.7%; Agreement to Provide NOVI Space with Rollable PV Array Blankets for Space Launch in 2026
  • Urgent Reform Demanded to Stop Child Abuse in Youth Behavioral Facilities
  • Cyrus O'Leary's Mini Cream Pies - The Latest Dessert Innovation from Sara Lee Frozen Bakery Delivers Indulgence in Single-Servings
_catLbl0 _catLbl1

Popular on Washingtoner

  • City of Spokane, City of Spokane Valley Sign Interlocal Agreement with Spokane County to Coordinate Homelessness Response - 2294
  • Assent Launches Carbon Border Adjustment Mechanism Solution to Help Manufacturers Meet Regulatory Requirements - 206
  • 150% Increase in Fiscal Q2 Sales vs Previous Year to $750,000; Continuous Record Quarters & Profitability for Homebuilding Product: Innovative Designs - 203
  • Sequentex Achieves OMNIA Partners Approval, Empowering Public Sector and other Agencies with Streamlined Technology Procurement - 202
  • The Great Reset, the First Photorealistic AI Film Makes History at the Cannes Film Festival - 185
  • Perspectives: Jellyfish Publication of an exciting new human clinical trial of proprietary KollaJell™ collagen peptide formulation - 150
  • Deadline Extended: More Time to Submit Your Proposal for the OpenSSL Conference 2025 - 124
  • Juventix Regenerative Medical Announces Strategic Partnership with Juvasonic® to Expand Needle-Free Biologic Delivery Platform - 120
  • Travel Industry Sounds Alarm: Expedia and Leaders Confront U.S. Tourism Concerns - 111
  • Award-winning NJ Author Celebrates New Release and Multi-Author Collaboration - 101

Similar on Washingtoner

  • Edtech Startup Young Commanders Launches 'Visionaries Without Sight' Collection Celebrating Blind and Visually Impaired Historical Figures
  • Goldstar Rehabilitation Celebrates 15 Years of Early Intervention Across Southeastern PA
  • United States Congressional Candidate Peter Coe Verbica Unveils 25-Point Federal Plan to Help Make California Affordable Again
  • Experience Trembling Firsthand with the New AgeMan® Tremor Simulator
  • Robert Michael & Co. Launches New Real Estate Website to Serve Central Florida Homebuyers and Sellers
  • WOA Entertainment Group Unveils Independent No.1's: Breakthrough Artists II —A Celebration of Indie Excellence
  • From Hotel Discomfort to Bamboo Bliss: BedVoyage Redefines Travel Sleep
  • DealMagik Successfully Concludes National Floral Design Contest with Over 150 Submissions
  • Behavioral Health Advocates to Hold Joint Capitol Hill Press Conference on June 11
  • Urgent Reform Demanded to Stop Child Abuse in Youth Behavioral Facilities
Copyright © 2025 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute